Comparison of Flt3 expression levels on HSC and MPP subsets. LT-and ST-HSCs were FACS purified using expression markers and gating strategies as shown in Fig. 1 , and APC-antic-Kit (2B8). MEPs were defined as Thy-1.
. CLPs were purified as described previously (3) and were defined as IL-7Rα
+ Thy-1.
For analysis of EGFP donor-derived GM, T, and B cells in reconstituted mice, peripheral blood was collected and treated with ACK buffer to remove red blood cells. Cells were then stained with PE/Cy7-anti-CD45.1 (A20), PE-, or APC-conjugated anti-lineage markers in combinations as described in the figure legends. To analyze surface phenotypes of B220 + cells in peripheral blood, APC-anti-B220 (RA3-6B2), PE-anti-CD19 (6D5), and FITC-anti-Igμ chain (goat polyclonal antibody) were used. For analysis of CD3 + cells, PE-CD3ε (145-2C11), APC-TCRβ (H57-597), and PE/Cy7-NK1.1 (PK136) were used. For platelet detection, peripheral blood was first stained with PE/Cy7-anti-CD45.1 (A20), PE-anti-CD41 (MWReg30), and biotinylated anti-CD61 (2C9.G3), followed by strepavidin-APC staining. To detect donor-derived CMPs, GMPs, and MEPs, bone marrow cells harvested from recipient mice were stained with PE/Cy7-anti-CD45.1 (A20), FITC-anti-CD45.2 (clone 104), and antibodies for MEPs as described above, except for FITC-anti-CD34. To detect CD34 expression, cells were instead stained with biotinylated-anti-CD34 (RM34), followed by strepavidin-APC/Cy7. CMPs and GMPs were defined as Thy-1.
+ FcγR + , respectively. All antibodies were purchased from eBioscience except for FITC-and biotinylated anti-CD34, PE-antiFcγR, PE-anti-CD41, and PE/Cy7-NK1.1, which were obtained from BD Biosciences. FITC-Igμ was purchased from SouthernBiotech. Anti-Sca-1 antibodies were purified and conjugated with Alexa Fluor 594 as described previously (4). 
